SEI INVESTMENTS CO - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 186 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,021,033
+162.8%
37,474
+114.6%
0.00%
+100.0%
Q2 2023$388,562
+4.6%
17,466
+1.8%
0.00%0.0%
Q1 2023$371,634
+27.0%
17,163
+19.2%
0.00%0.0%
Q4 2022$292,610
-65.9%
14,402
-57.0%
0.00%
-50.0%
Q3 2022$859,000
+118.0%
33,520
+130.1%
0.00%
+100.0%
Q2 2022$394,000
+7.4%
14,565
+3.0%
0.00%0.0%
Q1 2022$367,000
-38.5%
14,138
-38.1%
0.00%
-50.0%
Q4 2020$597,000
-27.3%
22,822
-51.6%
0.00%0.0%
Q3 2020$821,000
-36.2%
47,181
-38.3%
0.00%
-50.0%
Q2 2020$1,286,000
+41.3%
76,450
-0.1%
0.00%
+33.3%
Q1 2020$910,000
+82.0%
76,550
+85.4%
0.00%
+200.0%
Q4 2019$500,000
-25.1%
41,284
-12.7%
0.00%
-50.0%
Q3 2019$668,000
+12.5%
47,282
-11.2%
0.00%0.0%
Q2 2019$594,000
+63.2%
53,271
+71.8%
0.00%
+100.0%
Q1 2019$364,000
-51.2%
31,016
-40.9%
0.00%
-66.7%
Q4 2018$746,000
+1.9%
52,477
+0.5%
0.00%0.0%
Q3 2018$732,000
+297.8%
52,233
+345.6%
0.00%
+200.0%
Q2 2018$184,000
-21.7%
11,721
-17.9%
0.00%0.0%
Q1 2018$235,000
-33.4%
14,279
-27.0%
0.00%0.0%
Q4 2017$353,000
+4.1%
19,550
+11.3%
0.00%0.0%
Q3 2017$339,000
+621.3%
17,562
+344.8%
0.00%
Q2 2017$47,000
+46.9%
3,948
+35.5%
0.00%
Q1 2017$32,000
+39.1%
2,913
-7.8%
0.00%
Q4 2016$23,0003,1580.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders